Target Price | $294.78 |
Price | $274.92 |
Potential | 7.22% |
Number of Estimates | 20 |
20 Analysts have issued a price target Travelers 2026 . The average Travelers target price is $294.78. This is 7.22% higher than the current stock price. The highest price target is $336.00 22.22% , the lowest is $228.82 16.77% . | |
A rating was issued by 28 analysts: 11 Analysts recommend Travelers to buy, 15 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Travelers stock has an average upside potential 2026 of 7.22% . Most analysts recommend the Travelers stock at Hold. |
17 Analysts have issued a sales forecast Travelers 2025 . The average Travelers sales estimate is $45.6b . This is 4.70% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $47.8b 0.01% , the lowest is $43.9b 8.15% .
This results in the following potential growth metrics:
2024 | $46.4b | 12.23% |
---|---|---|
2025 | $45.6b | 1.79% |
2026 | $47.6b | 4.33% |
2027 | $49.4b | 3.94% |
2028 | $51.1b | 3.28% |
2029 | $52.6b | 3.09% |
2 Analysts have issued an Travelers EBITDA forecast 2025. The average Travelers EBITDA estimate is $7.4b . This is 50.03% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.7b 48.05% , the lowest is $7.2b 51.51% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $14.3b | 33.28% |
---|---|---|
2025 | $7.4b | 48.27% |
2026 | $8.7b | 18.30% |
2027 | $7.9b | 9.56% |
2024 | 30.74% | 18.75% |
---|---|---|
2025 | 16.19% | 47.33% |
2026 | 18.36% | 13.40% |
2027 | 15.97% | 13.02% |
25 Travelers Analysts have issued a net profit forecast 2025. The average Travelers net profit estimate is $4.3b . This is 17.17% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $4.9b 6.83% , the lowest is $3.7b 28.52% .
This results in the following potential growth metrics and future Net Margins:
2024 | $5.0b | 67.09% |
---|---|---|
2025 | $4.3b | 13.07% |
2026 | $5.6b | 29.10% |
2027 | $6.0b | 8.37% |
2028 | $4.7b | 22.30% |
2029 | $5.5b | 17.46% |
2024 | 10.69% | 48.88% |
---|---|---|
2025 | 9.46% | 11.48% |
2026 | 11.70% | 23.68% |
2027 | 12.20% | 4.27% |
2028 | 9.18% | 24.75% |
2029 | 10.46% | 13.94% |
25 Analysts have issued a Travelers forecast for earnings per share. The average Travelers EPS is $19.16 . This is 15.59% lower than earnings per share in the financial year 2024. The highest EPS forecast is $21.55 5.07% , the lowest is $16.53 27.18% .
This results in the following potential growth metrics and future valuations:
2024 | $21.47 | 67.87% |
---|---|---|
2025 | $19.16 | 10.76% |
2026 | $24.73 | 29.07% |
2027 | $26.80 | 8.37% |
2028 | $20.83 | 22.28% |
2029 | $24.46 | 17.43% |
Current | 12.11 | 11.64% |
---|---|---|
2025 | 14.35 | 18.49% |
2026 | 11.12 | 22.51% |
2027 | 10.26 | 7.73% |
2028 | 13.20 | 28.65% |
2029 | 11.24 | 14.85% |
Based on analysts' sales estimates for 2025, the Travelers stock is valued at an EV/Sales of 1.53 and an P/S ratio of 1.36 .
This results in the following potential growth metrics and future valuations:
Current | 1.46 | 12.31% |
---|---|---|
2025 | 1.53 | 5.05% |
2026 | 1.47 | 4.15% |
2027 | 1.41 | 3.80% |
2028 | 1.37 | 3.17% |
2029 | 1.33 | 3.00% |
Current | 1.29 | 15.52% |
---|---|---|
2025 | 1.36 | 4.93% |
2026 | 1.30 | 4.15% |
2027 | 1.25 | 3.80% |
2028 | 1.21 | 3.17% |
2029 | 1.18 | 3.00% |
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Neutral
➜
Neutral
|
Unchanged | Jul 21 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 18 2025 |
Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Jul 18 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 10 2025 |
Barclays |
Overweight
➜
Equal-Weight
|
Downgrade | Jul 07 2025 |
Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | May 28 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 19 2025 |
Analyst Rating | Date |
---|---|
Unchanged
UBS:
Neutral
➜
Neutral
|
Jul 21 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Jul 18 2025 |
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Jul 18 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Jul 10 2025 |
Downgrade
Barclays:
Overweight
➜
Equal-Weight
|
Jul 07 2025 |
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
May 28 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
May 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.